
Nordic Pharma partners with Harrow to launch an authorized generic of Maxitrol
Published on April 29, 2025

Maxitrol has been the leading corticosteroid/antibiotic combination drop for the treatment of ocular inflammation and bacterial infections for more than 50 years.
